Patents Assigned to OncoLogic Biopharmaceuticals Corporation
  • Use of autoantibodies for tumor therapy and prophylaxis
    Patent number: 5993818
    Abstract: A method of inhibiting the growth of a tumor cell in a mammal by administering to the mammal an autoantibody, e.g, an antinuclear autoantibody from an aged mammal, that binds to either one or both of a surface of a tumor cell and a protein released from a dead tumor cell. Also disclosed are natural and monoclonal antinuclear autoantibodies from aged mammals and a hybridoma cell line producing a monoclonal antinuclear autoantibody.
    Type: Grant
    Filed: July 14, 1998
    Date of Patent: November 30, 1999
    Assignee: OncoLogic Biopharmaceuticals Corporation
    Inventors: Vladimir P. Torchilin, Leonid Z. Iakoubov